Fewer than one-third of molecularly targeted cancer drugs recently approved by the US Food and Drug Administration (FDA) meet established European benchmarks for clinical benefits, according to a ...

Men diagnosed with metastatic hormone-sensitive prostate cancer who carry a specific tumor deficiency now have a targeted ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Cancer cells vis - 3d rendered image, enhanced scanning electron micrograph (SEM) of cancer ...

What Is It, and Why Does It Matter? Truqap (capivasertib) is an oral targeted cancer medicine. The FDA has now approved it to be used together with abiraterone and prednisone for a specific type of ...

Matthew Herper covers medical innovation — both its promise and its perils. The biotechnology firm Nuvalent said Monday that its drug for a genetically defined type of lung cancer shrank tumors in ...

Targeted compound daraxonrasib successfully blocks multiple KRAS variants to double survival limits in clinical trials.

June 3 (Reuters) - Cathy Smithwick, now 67, has lived with breast cancer, and then ovarian cancer, for more than 20 years with the help of targeted drugs, drugs that harness the body's immune system, ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Middle aged woman dressed in pink showing strength and smiling in a park. Fight against ...

RAS oncoproteins, once considered undruggable, are now being successfully targeted by new drugs like daraxonrasib, showing dramatically improved survival in pancreatic cancer patients. Personalized ...

Drug resistance remains one of the most formidable obstacles in cancer therapy, often arising when cells adapt to circumvent the mechanisms that drugs rely on. By distributing activity across multiple ...

US Pharmaceutical company Eli Lilly has launched a new cancer drug in India following approval from the Central Drugs ...